Halozyme Therapeutics, Inc. (HALO) Balance Sheet
HALO balance sheet, 2025
December 31, 2025 · U.S. dollars$2.53B assets = $2.48B liabilities + $48.8M equity
Both columns are drawn to the same scale: what HALO owns equals what it owes plus shareholders’ equity. Hover a block for its value.
HALO financial health
Descriptive bands, not a rating. Fiscal 2025.
HALO balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $261.5M2016 | $2.53B2025 | +28.7%/yr | |
| Total liabilities | $294.0M2016 | $2.48B2025 | +26.7%/yr | |
| Shareholders’ equity | −$32.5M2016 | $48.8M2025 | — | |
| Cash & short-term investments | $205.0M2016 | $142.8M2025 | −3.9%/yr | |
| Total debt | $216.6M2016 | $2.14B2025 | +29.0%/yr | |
| Net cash (debt) | −$11.6M2016 | −$2.00B2025 | −$2.0B | |
| Working capital | $201.9M2016 | $648.1M2025 | +$446.2M | |
| Book value per share | −$0.252016 | $0.392025 | — | |
| Current ratio | 4.702016 | 4.662025 | −0.04 | |
| Debt / equity | 0.972017 | 43.892025 | +42.92 | |
| Shares outstanding | 128.0M2016 | 123.9M2025 | −0.4%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
HALO assets
HALO liabilities and equity
HALO debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
HALO balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $142.8M | $596.1M | $336.0M | $362.8M | $740.9M | $368.0M | $421.3M | $354.5M | $469.2M | $205.0M |
| Cash & equivalents | $133.8M | $115.8M | $118.4M | $234.2M | $118.7M | $147.7M | $120.2M | $57.9M | $168.7M | $66.8M |
| Short-term investments | $9.0M | $480.2M | $217.6M | $128.6M | $622.2M | $220.3M | $301.1M | $296.6M | $300.5M | $138.2M |
| Receivables | $441.3M | $308.5M | $234.2M | $231.1M | $91.0M | $97.7M | $59.4M | $30.0M | $22.1M | $15.7M |
| Inventory | $176.5M | $141.9M | $127.6M | $100.1M | $53.9M | $60.7M | $29.4M | $22.6M | $5.1M | $14.6M |
| Other current assets | $64.6M | $39.0M | $48.6M | $45.0M | $40.5M | $28.3M | $33.4M | $20.7M | $13.9M | $21.2M |
| Total current assets | $825.2M | $1.09B | $746.4M | $739.0M | $926.3M | $554.8M | $543.4M | $427.8M | $510.4M | $256.5M |
| Property, plant & equipment (net) | $82.1M | $75.0M | $74.9M | $75.6M | $8.8M | $10.6M | $10.9M | $7.5M | $3.5M | $4.3M |
| Goodwill & intangible assets | $1.56B | $818.7M | $889.7M | $955.7M | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $56.2M | $84.5M | $22.2M | $71.2M | $169.3M | $14.6M | $11.6M | $4.9M | $6.1M | $719,000 |
| Total assets | $2.53B | $2.06B | $1.73B | $1.84B | $1.10B | $579.9M | $565.9M | $440.2M | $519.9M | $261.5M |
| Liabilities | ||||||||||
| Accounts payable | $20.9M | $10.2M | $11.8M | $17.7M | $1.5M | $1.9M | $6.4M | $4.1M | $7.9M | $3.6M |
| Short-term debt | — | — | $6.6M | $13.3M | $89.4M | $397.2M | $19.5M | $91.5M | $77.2M | $17.4M |
| Deferred revenue | — | — | −$32.2M | $3.2M | $1.7M | $1.7M | $4.0M | $4.2M | $6.6M | $4.8M |
| Total current liabilities | $177.1M | $139.1M | $112.5M | $130.8M | $117.1M | $421.4M | $85.6M | $149.4M | $131.3M | $54.6M |
| Long-term debt | $2.14B | $1.51B | $1.50B | $1.49B | $787.3M | $0 | $383.0M | $34.9M | $125.1M | $199.2M |
| Other long-term liabilities | $156.8M | $54.8M | $37.7M | $48.2M | $3.1M | $7.5M | $5.4M | $7.1M | $55.1M | $40.2M |
| Total liabilities | $2.48B | $1.70B | $1.65B | $1.67B | $907.5M | $428.9M | $474.1M | $191.4M | $311.6M | $294.0M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $118,000 | $123,000 | $127,000 | $135,000 | $138,000 | $135,000 | $137,000 | $145,000 | $143,000 | $130,000 |
| Retained earnings (deficit) | $54.8M | $359.9M | $90.5M | $143.2M | −$58.9M | −$474.6M | −$603.7M | −$531.4M | −$522.4M | −$585.3M |
| Treasury stock | — | — | — | — | — | — | — | — | $0 | $0 |
| Accumulated other comprehensive income | −$18.1M | $3.8M | −$9.3M | −$922,000 | −$620,000 | $22,000 | $240,000 | −$277,000 | −$450,000 | −$6,000 |
| Minority interest | — | — | — | — | — | — | — | — | $0 | $0 |
| Total shareholders' equity | $48.8M | $363.8M | $83.8M | $169.8M | $197.0M | $151.0M | $91.8M | $248.9M | $208.4M | −$32.5M |
| Key figures | ||||||||||
| Total debt | $2.14B | $1.51B | $1.50B | $1.51B | $876.7M | $397.2M | $402.6M | $126.4M | $202.4M | $216.6M |
| Net cash (debt) | −$2.00B | −$909.7M | −$1.16B | −$1.14B | −$135.8M | −$29.2M | $18.7M | $228.1M | $266.9M | −$11.6M |
| Working capital | $648.1M | $946.2M | $633.9M | $608.2M | $809.1M | $133.4M | $457.8M | $278.5M | $379.0M | $201.9M |
| Tangible book value | −$1.51B | −$454.8M | −$805.9M | −$785.9M | $197.0M | $151.0M | $91.8M | $248.9M | $208.4M | −$32.5M |
| Book value per share | $0.39 | $2.81 | $0.62 | $1.21 | $1.34 | $1.07 | $0.64 | $1.73 | $1.50 | −$0.25 |
| Shares outstanding | 123.9M | 129.4M | 134.2M | 140.6M | 146.8M | 141.5M | 144.3M | 143.6M | 139.1M | 128.0M |
| Current ratio | 4.66 | 7.80 | 6.64 | 5.65 | 7.91 | 1.32 | 6.35 | 2.86 | 3.89 | 4.70 |
| Quick ratio | 3.30 | 6.50 | 5.07 | 4.54 | 7.10 | 1.11 | 5.61 | 2.57 | 3.74 | 4.04 |
| Debt / equity | 43.89 | 4.14 | 17.89 | 8.87 | 4.45 | 2.63 | 4.39 | 0.51 | 0.97 | — |
| Equity / assets | 1.9% | 17.6% | 4.8% | 9.2% | 17.8% | 26.0% | 16.2% | 56.5% | 40.1% | −12.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $231.0M | $318.6M | $142.8M | $702.0M | $548.2M | $747.9M | $596.1M | $666.3M | $529.0M | $463.5M | $336.0M | $483.3M |
| Cash & equivalents | $163.1M | $309.7M | $133.8M | $419.7M | $61.9M | $176.3M | $115.8M | $154.3M | $187.9M | $164.6M | $118.4M | $274.2M |
| Short-term investments | $67.9M | $8.9M | $9.0M | $282.3M | $486.3M | $571.6M | $480.2M | $512.0M | $341.2M | $298.8M | $217.6M | $209.1M |
| Receivables | $455.8M | $458.0M | $441.3M | $346.0M | $316.3M | $304.6M | $308.5M | $285.7M | $214.5M | $195.9M | $234.2M | $217.3M |
| Inventory | $137.1M | $155.5M | $176.5M | $185.8M | $181.5M | $164.9M | $141.9M | $131.4M | $159.3M | $168.5M | $127.6M | $128.9M |
| Other current assets | $109.1M | $71.0M | $64.6M | $95.0M | $76.7M | $44.6M | $39.0M | $43.5M | $84.9M | $45.7M | $48.6M | $49.5M |
| Total current assets | $933.0M | $1.00B | $825.2M | $1.33B | $1.12B | $1.26B | $1.09B | $1.13B | $987.8M | $873.6M | $746.4M | $879.0M |
| Property, plant & equipment (net) | $84.3M | $82.2M | $82.1M | $71.4M | $71.5M | $72.8M | $75.0M | $74.5M | $75.0M | $78.1M | $74.9M | $74.7M |
| Goodwill & intangible assets | $1.50B | $1.53B | $1.56B | $765.4M | $783.1M | $800.9M | $818.7M | $836.4M | $854.2M | $871.9M | $889.7M | $907.5M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $55.9M | $53.2M | $56.2M | $55.7M | $76.6M | $60.8M | $84.5M | $80.2M | $52.5M | $17.9M | $22.2M | $31.5M |
| Total assets | $2.58B | $2.67B | $2.53B | $2.22B | $2.05B | $2.20B | $2.06B | $2.12B | $1.97B | $1.84B | $1.73B | $1.89B |
| Liabilities | ||||||||||||
| Accounts payable | $23.6M | $14.1M | $20.9M | $15.4M | $18.7M | $20.1M | $10.2M | $12.4M | $15.4M | $13.3M | $11.8M | $19.3M |
| Short-term debt | $209.0M | $208.7M | — | $710.7M | — | — | — | — | $30.7M | $31.8M | $32.2M | $32.4M |
| Deferred revenue | — | — | — | — | — | — | — | — | $29.3M | $19.1M | −$32.2M | $667,000 |
| Total current liabilities | $344.4M | $363.2M | $177.1M | $837.2M | $134.3M | $150.4M | $139.1M | $108.8M | $133.4M | $131.6M | $112.5M | $115.2M |
| Long-term debt | $1.94B | $1.94B | $2.14B | $800.1M | $1.51B | $1.51B | $1.51B | $1.50B | $1.50B | $1.50B | $1.50B | $1.50B |
| Other long-term liabilities | $151.7M | $154.0M | $156.8M | $80.0M | $77.8M | $56.4M | $54.8M | $52.4M | $44.2M | $31.2M | $37.7M | $30.7M |
| Total liabilities | $2.43B | $2.45B | $2.48B | $1.72B | $1.72B | $1.71B | $1.70B | $1.67B | $1.68B | $1.66B | $1.65B | $1.64B |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $114,000 | $118,000 | $118,000 | $118,000 | $118,000 | $123,000 | $123,000 | $127,000 | $127,000 | $127,000 | $127,000 | $132,000 |
| Retained earnings (deficit) | $151.3M | $204.8M | $54.8M | $502.1M | $361.0M | $478.0M | $359.9M | $397.6M | $260.6M | $167.4M | $90.5M | $222.3M |
| Accumulated other comprehensive income | −$7.8M | −$12.7M | −$18.1M | −$22.3M | −$28.4M | −$3.4M | $3.8M | −$6.9M | −$2.1M | −$1.5M | −$9.3M | $1.2M |
| Total shareholders' equity | $143.5M | $219.6M | $48.8M | $503.9M | $332.7M | $482.3M | $363.8M | $452.7M | $289.4M | $177.8M | $83.8M | $249.2M |
| Key figures | ||||||||||||
| Total debt | $2.15B | $2.14B | $2.14B | $1.51B | $1.51B | $1.51B | $1.51B | $1.50B | $1.50B | $1.50B | $1.50B | $1.50B |
| Net cash (debt) | −$1.92B | −$1.83B | −$2.00B | −$808.8M | −$960.9M | −$759.5M | −$909.7M | −$837.8M | −$973.5M | −$1.04B | −$1.16B | −$1.01B |
| Working capital | $588.6M | $639.8M | $648.1M | $491.5M | $988.4M | $1.11B | $946.2M | $1.02B | $854.4M | $741.9M | $633.9M | $763.8M |
| Tangible book value | −$1.36B | −$1.31B | −$1.51B | −$261.4M | −$450.4M | −$318.6M | −$454.8M | −$383.7M | −$564.8M | −$694.1M | −$805.9M | −$658.3M |
| Book value per share | $1.18 | $1.79 | $0.41 | $4.12 | $2.68 | $3.81 | $2.81 | $3.48 | $2.24 | $1.38 | $0.64 | $1.86 |
| Shares outstanding | 121.2M | 122.9M | 117.7M | 122.3M | 124.2M | 126.6M | 129.4M | 130.1M | 129.2M | 128.9M | 131.0M | 134.1M |
| Current ratio | 2.71 | 2.76 | 4.66 | 1.59 | 8.36 | 8.39 | 7.80 | 10.36 | 7.41 | 6.64 | 6.64 | 7.63 |
| Quick ratio | 1.99 | 2.14 | 3.30 | 1.25 | 6.44 | 7.00 | 6.50 | 8.75 | 5.58 | 5.01 | 5.07 | 6.08 |
| Debt / equity | 14.95 | 9.76 | 43.89 | 3.00 | 4.54 | 3.13 | 4.14 | 3.32 | 5.19 | 8.44 | 17.89 | 6.01 |
| Equity / assets | 5.6% | 8.2% | 1.9% | 22.7% | 16.2% | 22.0% | 17.6% | 21.4% | 14.7% | 9.7% | 4.8% | 13.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 17, 2026); data from EODHD.
HALO financial position
At the end of fiscal 2025 (December 31, 2025), Halozyme Therapeutics had total assets of $2.5 billion (up 22.4% from a year earlier), total liabilities of $2.5 billion and shareholders' equity of $48.8 million. It held $142.8 million in cash and short-term investments against $2.1 billion of debt, net debt of $2.0 billion. Its current ratio was 4.66. In the latest quarter (ended June 30, 2026) total assets were $2.6 billion and equity $143.5 million.
Related: HALO income statement, HALO cash flow statement, HALO key metrics. See the HALO stock overview for the latest quote and news.
HALO balance sheet FAQ
What are Halozyme Therapeutics's total assets?
Halozyme Therapeutics reported total assets of $2.5 billion at the end of fiscal 2025 (December 31, 2025), compared with $2.1 billion a year earlier.
How much debt does Halozyme Therapeutics have?
Halozyme Therapeutics had $2.1 billion of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 43.89.
How much cash does Halozyme Therapeutics have?
Halozyme Therapeutics held $142.8 million in cash and short-term investments at the end of fiscal 2025; with $2.1 billion of debt that is net debt of $2.0 billion.
What is Halozyme Therapeutics's book value?
Halozyme Therapeutics's shareholders' equity (book value) was $48.8 million at the end of fiscal 2025, or $0.39 per share.
What is Halozyme Therapeutics's current ratio?
Halozyme Therapeutics had current assets of $825.2 million and current liabilities of $177.1 million, a current ratio of 4.66 (it can cover its short-term obligations).
How much goodwill does Halozyme Therapeutics have?
Halozyme Therapeutics carried $1.6 billion of goodwill and intangible assets, 61.8% of total assets, at the end of fiscal 2025.